(MedPage Today) — The FDA approved dupilumab (Dupixent) for treating allergic fungal rhinosinusitis, a first for the condition, the agency announced on Wednesday.
Approval stipulates use in individuals 6 years and older with prior sino-nasal…
Source link : https://www.medpagetoday.com/allergyimmunology/allergy/120042
Author :
Publish date : 2026-02-25 19:11:00
Copyright for syndicated content belongs to the linked Source.
